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ttp://dx.doi.org/10.1016/j.ajpath.2014.05.018Mild to moderate hyperhomocysteinemia is prevalent in humans and is implicated in neurovascular dis-
eases, including recently in certain retinal diseases. Herein, we used hyperhomocysteinemicmice deﬁcient
in the Cbs gene encoding cystathionineeb-synthase (Cbsþ/) to evaluate retinal vascular integrity. The
Cbsþ/þ (wild type) and Cbsþ/ (heterozygous) mice (aged 16 to 52 weeks) were subjected to ﬂuorescein
angiography and optical coherence tomography to assess vasculature in vivo. Retinas harvested for cry-
osectioning or ﬂat mount preparations were subjected to immunoﬂuorescence microscopy to detect blood
vessels (isolectin-B4), angiogenesis [anti-vascular endothelial growth factor (VEGF) and anti-CD105],
gliosis [anti-glial ﬁbrillary acidic protein (GFAP)], pericytes (anti-neural/glial antigen 2), blood-retinal
barrier [antiezonula occludens protein 1 (ZO-1) and anti-occludin], and hypoxia [antiepimonidazole
hydrochloride (Hypoxyprobe-1)]. Levels of VEGF, GFAP, ZO-1, and occludin were determined by immu-
noblotting. Results of these analyses showed a mild vascular phenotype in young mice, which progressed
with age. Fluorescein angiography revealed progressive neovascularization and vascular leakage in Cbsþ/
mice; optical coherence tomography conﬁrmed new vessels in the vitreous by 1 year. Immunoﬂuorescence
microscopy demonstrated vascular patterns consistent with ischemia, including a capillary-free zone
centrally and new vessels with capillary tufts midperipherally in older mice. This was associated with
increased VEGF, CD105, and GFAP and decreased ZO-1/occludin levels in the Cbsþ/ retinas. Retinal vein
occlusion was observed in some Cbsþ/ mouse retinas. We conclude that mild to moderate elevation of
homocysteine in Cbsþ/ mice is accompanied by progressive alterations in retinal vasculature charac-
terized by ischemia, neovascularization, incompetent blood-retinal barrier, and vascular occlusion.
(Am J Pathol 2014, 184: 2573e2585; http://dx.doi.org/10.1016/j.ajpath.2014.05.018)Supported by NIH grant R01 EY012830 and the James and Jean Culver
Vision Discovery Institute.
Disclosures: None declared.Homocysteine (Hcy), a sulfur-containing amino acid, is an
intermediate in methionine metabolism. It is converted to either
methionine, via the remethylation pathway, or cysteine for
permanent disposal via the trans-sulfuration pathway. Hyper-
homocysteinemia (HHcy) results from increased Hcy dietary
loading (eg, diet rich in methionine), decreased rates of Hcy
metabolism due to deﬁciency of vitamin cofactors (folic acid
and vitamins B6 and B12), or genetic mutations of enzymes
involved in remethylation or trans-sulfuration pathways. Mild
to moderate HHcy is prevalent in 5% to 10% of the general
population, up to 90% of patients undergoing hemodialysis,stigative Pathology.
.and approximately 40% of patients with peripheral vascular
disease.1,2 HHcy is a risk factor for human cardiovascular
diseases (eg, stroke and venous thrombosis) and neurodegen-
erative diseases.3 It has been implicated in eye-related diseases,
including ectopia lentis,4 glaucoma (primary and secondary
open-angle glaucoma, exfoliation glaucoma, and pigmentary
glaucoma),5e7 macular degeneration, maculopathy, retinal
Tawﬁk et aldegeneration,8e10 diabetic retinopathy,11,12 and retinal vascular
diseases (ie, central retinal vein occlusion, branch retinal vein
occlusion, and central retinal artery occlusion13e16), although
its role in these diseases is inconsistent.
Our laboratory and others have used in vitro and in vivo
experimental models to understand the mechanisms by which
HHcy affects retina. Apoptotic neuronal cell death was
induced in primary mouse retinal ganglion cells incubated
with elevated, but physiologically relevant, levels of Hcy (50
mmol/L).17 In vivo studies showed that intravitreal injection of
high dosages of D,L-Hcy-thiolactone led to marked ganglion
cell loss and disruption of the inner retina in mice within 5
days of injection.18 Lower-dosage D,L-Hcy-thiolactone intra-
vitreal injections led to marked loss of photoreceptor cells
within 15 days and ablation of the outer retinal nuclear layer
within 90 days.19 Mice deﬁcient or lacking the gene encoding
cystathionineeb-synthase (CBS)20 have proved useful for
analysis of the effects of mild to severe endogenous elevation
of Hcy on several tissues, including retina.21e26 CBS is a key
enzyme in the trans-sulfuration pathway, and its deﬁciency is
the most common cause of inherited homocystinuria.4
The Cbs/ mice have a 30- to 40-fold increase in plasma
Hcy20 and a shortened life span of 3 to 5 weeks. Retinal Hcy
levels are increased by approximately sevenfold in Cbs/
mice compared with age-matched wild-type littermates.22
Functional studies of the visual system in these mice reveal
signiﬁcantly reduced amplitudes of the dark- and light-adapted
electroretinogram (ERG) and a marked delay in the N1 im-
plicit time of the visual-evoked potential, which reﬂects signal
transmission to the visual cortex.25 Comprehensive histolog-
ical assessment of Cbs/ retinas demonstrates profound loss
of cells in the retinal ganglion cell layer, marked disruption of
the inner/outer nuclear retinal layers, and hypertrophy of the
retinal pigment epithelial cell layer.22
Functional studies of retinas of Cbsþ/mice, which have a
much milder HHcy with an approximately fourfold to
sevenfold increase in plasma Hcy (and a twofold increase in
retinal Hcy), reveal a gradual reduction of the light and dark
amplitudes of the ERG, reduced direct-coupled ERG light
peak, and a slight increase in the implicit times of the visual-
evoked potential.25 Histological analyses of Cbsþ/ mouse
retinas show a much milder retinal phenotype than Cbs/
mice, characterized by moderate cell loss in the ganglion cell
layer and decreased thickness of the inner plexiform and
inner and outer nuclear layers.22 Altered mitochondria of the
nerve ﬁber layer and increased expression of the mitochon-
drial proteins, Opa1 and Fis1, accompanied the retinal gan-
glion cell loss.24 The functional deﬁcits and histological
alterations in the Cbsþ/ mouse become evident by approx-
imately 30 weeks of age.22,25
Recently, we analyzed the retinal vasculature of Cbs/
mice to determine whether the profound neuronal degeneration
of the retina was accompanied by a vascular phenotype.26 The
study was restricted to mice aged 3 weeks owing to the short
life span of the homozygous (Cbs/) mice. Angiography
revealed considerable vascular leakage in Cbs/ retinas, and2574the immunohistochemical analysis revealed vascular patterns
consistent with ischemia. Vascular endothelial growth factor
(VEGF), a marker of new blood vessels, was increased in
Cbs/ retinas, and the blood-retinal barrierwas compromised.
In this same study, the vasculature of the heterozygous (Cbsþ/)
mice at 3 weeks showedminimal evidence of vasculopathy, but
raised the question as to whether retinal vascular alterations
would be detectable with advancing age. Because mild HHcy
is common in the human population, the present study investi-
gated the retinal vasculature of theCbsþ/mice as a function of
age. Our data demonstrate subtle vascular changes early that
become more prominent by 4 months of age and progress to
ischemia and neovascularization by 6 to 12 months of age.
Materials and Methods
Animals
The generation of mice deﬁcient in cbs has been reported.20
Breeding pairs of Cbsþ/ mice (B6.129P2-Cbstm1Unc/J; Jack-
son Laboratories, Bar Harbor, ME) were used to establish our
colony of Cbsþ/þ, Cbsþ/, and Cbs/ mice. Genotyping,
husbandry, and housing conditions for the mice have been
described.22 For analysis of retinal vasculature, 122 wild-type
(Cbsþ/þ) and heterozygous (Cbsþ/) mice were used at ages
ranging from 3 to 52 weeks. The ages and numbers of mice
used are indicated in Table 1. Experiments were approved by
the Institutional Animal Care and Use Committee of Georgia
Regents University (Augusta) and adhered to the Association
for Research in Vision and Ophthalmology Statement for the
Use of Animals in Ophthalmic and Vision Research.
Fluorescein Angiography
To evaluate retinal vasculature and permeability in live mice,
Cbsþ/þ and Cbsþ/ mice were anesthetized using 20 mL
intramuscular injection of rodent anesthesia cocktail (keta-
mine, 100mg/mL; xylazine, 30mg/mL; and acepromazine, 10
mg/mL). Pupils were dilated using 1% tropicamide (Bausch
and Lomb Corp., Rochester, NY). The mouse was placed on
the imaging platform of the PhoenixMicron III retinal imaging
microscope (Phoenix Research Laboratories, Pleasanton, CA),
and hypromellose (2.5% Goniovisc; Sigma Pharmaceuticals,
LLC, Monticello, IA) was applied liberally to retain surface
moisture during imaging. Mice were administered an i.p. in-
jection of 10 to 20 mL of ﬂuorescein sodium (10%Lite; Apollo
Ophthalmics, Newport Beach, CA) (while also receiving 2.5%
Goniovisc). Rapid acquisition of ﬂuorescent images ensued
for approximately 5 minutes. Mice were analyzed at 16, 24,
36, and 52 weeks, as described.26
SD-OCT Imaging
Mice were anesthetized, and their pupils were dilated as
described above. Lubricant Eye Gel (GenTeal; Novartis
Pharmaceuticals, East Hanover, NJ) was used throughout
the procedure to maintain corneal moisture and clarity. Miceajp.amjpathol.org - The American Journal of Pathology
Table 1 Summary of Mice (Age and Body Weights) Used in the
Analyses
Mouse
genotype
No. of
mice
Mouse age
(weeks)
Mean body
weight  SEM
(grams)
Fluorescein angiography and SD-OCT
Cbsþ/þ 5 16 23.2  0.8
Cbsþ/ 4 16 28.7  1.2
Cbsþ/þ 3 24 24.5  2.5
Cbsþ/ 5 24 32.3  2.6
Cbsþ/þ 3 36 22.5  1.1
Cbsþ/ 3 36 25.6  0.8
Cbsþ/þ 3 52 32.6  0.3
Cbsþ/ 3 52 28.8  2.2
Quantitative vascular assessment in retinal ﬂat-mounted
preparations stained with isolectin-B4
Cbsþ/þ 6 21 25.1  0.9
Cbsþ/ 6 21 27.7  2.7
Retinal ﬂat-mounted preparations isolectin-B4, HP-1, ZO-1,
and occludin
Cbsþ/þ 6 16 25.3  1.8
Cbsþ/ 5 16 25.6  1.1
Cbsþ/þ 3 24 25.1  0.9
Cbsþ/ 5 24 27.7  2.7
Cbsþ/þ 9 36 29.5  20
Cbsþ/ 10 36 24.9  0.5
Cbsþ/þ 8 52 32.7  0.4
Cbsþ/ 7 52 26.8  1.4
Retinal cryosections of VEGF, CD-105, and GFAP
Cbsþ/þ 4 36 30.0  2.2
Cbsþ/ 4 36 25.4  0.9
Cbsþ/þ 3 52 32.3  0.3
Cbsþ/ 3 52 26.3  0.4
Retinal immunoblotting for detection of VEGF, GFAP, ZO-1,
and occludin
Cbsþ/þ 4 36 32.5  3.5
Cbsþ/ 4 36 24.4  1.0
Cbsþ/þ 3 52 32.3  0.3
Cbsþ/ 3 52 25.4  0.9
Mild HHcy and Retinal Vasculopathywere placed within the cassette, and spectral domain optical
coherence tomography (SD-OCT) images were obtained
using the Bioptigen Spectral Domain Ophthalmic Imaging
System (model Envisu R2200; Bioptigen, Inc., Morrisville,
NC) equipped with the mouse retina probe using proprietary
Bioptigen software version 2.2. Three repeated-volume in-
tensity projections, centered on the optic nerve head, were
acquired for each eye. The images consisted of 100 averaged
B-scans. Collection of the data permitted three-dimensional
renderings of the retina. In some cases, Doppler imaging was
performed during the scan to visualize blood vessels. Care
was taken to ensure that all three scans were acquired before
the mice developed reversible cataract. Images were acquired
within 20 minutes after anesthesia administration.
Isolectin-B4 Staining of Flat-Mounted Retinal
Preparations and Quantitative Assessment
To visualize retinal vasculature in ﬁxed tissue, retinal ﬂat
mounts were prepared as described.26 Brieﬂy, eyes were
enucleated and incubated in 4% paraformaldehyde overnight,
and retinas were dissected and incubated with the endothelial
cellespeciﬁc marker, biotinylated Griffonia simplicifolia
isolectin-B4, overnight at 4C, followed by incubation with
avidin-conjugated Texas Red (Vector Labs, Burlingame,
CA). Retinas were cut partially at four places along the rim to
allow the tissue to be ﬂattened on Superfrost microscope
slides (Fisher Scientiﬁc, Pittsburgh, PA). Retinal ﬂat mount
preparations were visualized by immunoﬂuorescence using
an Axioplan-2 ﬂuorescent microscope (Carl Zeiss, Göttin-
gen, Germany) equipped with a high-resolution microscope
camera. Images were captured and processed using Zeiss
Axiovision digital image processing software version 4.7.
Using retinal ﬂat mount preparations stained with
isolectin-B4, images were captured by immunoﬂuorescence,
and were then subjected to quantitative analysis of arteriole
and venue widths using the ImageJ program version 1.45
(NIH, Bethesda, MD). The arteriole/venule ratios were calcu-
lated subsequently.27
Immunoﬂuorescent Assessment of Vascular Markers in
Retinal Cryosections
A battery of antibody markers were used in immunoﬂuores-
cence experiments to detect new blood vessel formation
(anti-VEGF and anti-CD105), evidence of gliosis [anti-glial
ﬁbrillary acidic protein (GFAP)], pericytes [anti-neural/glial
antigen (NG2)], and integrity of the blood-retinal barrier using
markers for tight junction proteins [antiezonula occludens
protein 1 (ZO-1) and anti-occludin]. The commercial sources
and ﬁnal concentrations of primary and secondary antibodies
are provided in Table 2. Retinal cryosections were prepared
from Cbsþ/þ and Cbsþ/ mice, as previously reported.26 Sec-
tionswere ﬁxedwith 4%paraformaldehyde and incubated with
Power Block (BioGenex, San Ramon, CA), followed by incu-
bation with primary antibody for either 3 hours at 37C orThe American Journal of Pathology - ajp.amjpathol.orgovernight at 4C. Sections were incubated with secondary
antibodyandcoverslippedwithFluoroshieldwithDAPI (Sigma
Chemical Corp., St. Louis, MO) to label nuclei. Sections were
examined by epiﬂuorescence, as described above. The intensity
of ﬂuorescence was analyzed using MetaMorph Image Anal-
ysis software version 6.3 (Molecular Devices, Sunnyvale, CA).
Quantitative RT-PCR
Neural retinas were isolated fromCbsþ/þ andCbsþ/mice (12
and 52 weeks); RNA was extracted as previously described.24
Quantitative real-time PCR was performed using Absolute
QPCR SYBR Green Fluorescein Mix from ABgene (Thermo
Scientiﬁc, Surrey, UK) and the BioRad icycler (BioRad,
Hercules, CA). The primers used for quantitative PCR (qPCR)
were as follows: VEGF120 (forward), 50-CATCTTCAAG-
CCGTCCTGTGTGC-30; and VEGF120 (reverse), 50-CAC-
CGCCTTGGCTTGTCACATT-30. PCR was performed for2575
Table 2 Primary and Secondary Antibodies Used to Analyze Retinal Vasculature
Primary antibody (catalog no.) Vendor Concentration Vasculature identiﬁed Secondary antibody
Griffonia simplicifolia
isolectin-B4 (B-1105)
Vector Labs
(Burlingame, CA)
7.5 mL/mL Vessels; detects vessel
patterns
Texas Red avidin:
7 mL/mL (Vector Labs)
CD105 (endoglin),
rat anti-mouse
(lot 75,619)
BD Biosciences
(San Jose, CA)
1:25 Angiogenesis Alexa Fluor 555
(donkey anti-rat)
(Invitrogen, Eugene, OR)
VEGF mouse monoclonal
IgM (AB 38909)
Abcam Corp.
(Cambridge, MA)
1:250 Angiogenesis Alexa Fluor 488
(donkey anti-mouse)
(Invitrogen)
GFAP rabbit polyclonal
(lot 00019620)
DakoCytomation
(Carpinteria, CA)
1:100 Stressed Mu¨ller cells
and astrocytes
Alexa Fluor 488
(goat anti-rabbit)
(Invitrogen)
ZO-1 Rb.PAbzo-1 tight
junction (AB 59720)
Abcam Corp. 1:250 Cellular tight junctions Alexa Fluor 488
(donkey anti-rabbit)
(Invitrogen)
Occludin rabbit
polyclonal (AB 31721)
Abcam Corp. 1:200 Cellular tight junctions Alexa Fluor 488
(donkey anti-rabbit)
(Invitrogen)
Occludin mouse monoclonal
(catalog no. 33e1500)
Invitrogen 1:200 Cellular tight junctions Alexa Fluor 488
(donkey anti-mouse)
(Invitrogen)
IgM mouse monoclonal
(AB 18401)
Abcam Corp. 1:200 Isotype control
(VEGF study)
Alexa Fluor 488
(donkey anti-mouse)
(Invitrogen)
Hypoxyprobe Plus Kit
(item HP2-100Kit)
Hypoxyprobe
(Burlington, MA)
1:50 Hypoxic tissue Alexa Fluor 488
(goat anti-mouse)
(Invitrogen)
NG2 chondroitin sulfate
(AB5320)
Abcam Corp. 1:200 Pericytes Alexa Fluor 488
(donkey anti-rabbit)
(Invitrogen)
Tawﬁk et al40 cycles of 95C for 30 seconds, 60C for 30 seconds, and
72C for 30 seconds; melt curve analysis conﬁrmed the purity
of the end products. Resulting CT values were normalized to
18 seconds and analyzed using the comparative CT method to
obtain fold changes in gene expression.Immunoblotting to Detect Levels of VEGF, ZO-1, and
Occludin
Proteins were extracted from neural retinas isolated from
Cbsþ/þ andCbsþ/mice to detect VEGF, ZO-1, and occludin
levels, as previously described.26 Brieﬂy, protein samples
were subjected to SDS-PAGE and transferred to nitrocellu-
lose membranes, which were then incubated with mouse
monoclonal anti-VEGF antibody (1:200), rabbit polyclonal
anti-GFAP antibody (1:100), rabbit polyclonal antieZO-1
antibody (1:100), and rabbit polyclonal anti-occludin anti-
body (1:100) at 4C overnight, followed by a horseradish
peroxidaseeconjugated goat anti-mouse IgG (1:5000) or goat
anti-rabbit IgG (1:3000) antibody. Proteins were visualized
with the enhanced chemiluminescence Western blot analysis
detection system. Membranes were reprobed with mouse
monoclonal antieb-actin antibody (1:5000) as a loading con-
trol. Protein levels were quantiﬁed as previously described.262576In addition, we evaluated the levels of mRNA encoding
VEGF by quantitative RT-PCR, as described.26
Detection of Tissue Hypoxia
To determine whether moderate HHcy is associated with retinal
hypoxia, the Hypoxyprobe Plus Kit (Hypoxyprobe Co, Bur-
lington, MA) was used. One hour before mice were euthanized,
60 mg pimonidazole hydrochloride [Hypoxyprobe-1 (HP-1),
which binds to proteins in hypoxic cells] per kg body weight
was injected into the peritoneal cavities of mice. Retinal ﬂat
mounts were prepared as described above. After incubation
with Power Block, retinas were incubated with ﬂuorescein
isothiocyanateeconjugated mouse monoclonal antibody
against HP-1 (1:50 dilution) and isolectin-B4 overnight at 4C.
The retinas were subsequently incubated with Alexa Fluor
488econjugated goat antibodies against mouse immunoglob-
ulins and avidin-conjugated Texas Red (1 hour at 37C).
Retinal ﬂat mount preparations were visualized by immuno-
ﬂuorescence, as described above.
Electron Microscopy
Mouse eyes were enucleated and ﬁxed for 1 hour at room
temperature in 2% paraformaldehyde/2% glutaraldehyde inajp.amjpathol.org - The American Journal of Pathology
Mild HHcy and Retinal Vasculopathy0.1 mol/L sodium cacodylate buffer in sucrose (pH 7.2) and
post-ﬁxed for 1 hour with osmium tetroxide. Eyes were
punctured at the limbus, ﬁxed overnight, washed in sodium
cacodylate buffer, dehydrated in serial ethanol (70% to
100%), inﬁltrated with propylene oxide, and inﬁltrated with
Epon/propylene oxide (1:1) at room temperature for 1 hour.
Eyes were polymerized overnight in fresh Epon, and
embedded in resin mixture (EM-bed 812/Araldite-502;
Electron Microscopy Sciences, Hatﬁeld, PA). Sections (90
nm thin) were cut with a diamond knife on an ultramicro-
tome (model EM UC6; Leica Microsystems, Inc., Ban-
nockburn, IL) and placed on copper grids. Sections were
stained with uranyl acetate and lead citrate and viewed using
a transmission electron microscope (model JEM 1230;
JEOL USA, Inc., Peabody, MA) at 110 kV and imaged with
a charge-coupled device camera (UltraScan4000/First Light
Digital Camera Controller; Gatan Inc., Pleasanton, CA).
Statistical Analysis
MetaMorph quantiﬁcation of immunoﬂuorescence detection
of vascular markers (isolectin-B4, VEGF, GFAP, ZO-1, and
occludin), data from ImageJ and FIJI analysis (an advanced
software version of ImageJ), and densitometric scans for
Western blot analysis were analyzed by Student’s t-test using
the GraphPad Prism software version 6 (GraphPad Software
Inc., La Jolla, CA). The data were reported as means  SEM.
P < 0.05 was considered signiﬁcant.
Results
Results of FA and OCT
Fluorescein angiography (FA) was performed in Cbsþ/þ and
Cbsþ/ mice (aged 16 to 52 weeks). Images were collected
immediately after ﬂuorescein administration, then every
minute thereafter for 5 minutes. After capture, the images
were arranged according to capture time and data were
compared for the Cbsþ/þ and Cbsþ/ mice at the same time
interval. Representative data for Cbsþ/þ and Cbsþ/ mice
(aged 16, 24, and 52 weeks) are shown in Figure 1, AeH.
The angiograms for Cbsþ/þ mice showed normal vessel
ﬁlling patterns with no observable ﬂuorescein leakage into
surrounding tissue. In the Cbsþ/ mouse group at 16 and 24
weeks, the threshold feature did not reveal evidence of
marked vasculopathy, whereas at 52 weeks, Cbsþ/ mutant
mouse clearly demonstrated evidence of new vessels, a
network of small vessels in the background (Figure 1C).
Appearance of a healthy retina was evident in the 24-week-
old Cbsþ/þ mouse (Figure 1D), which showed larger vessels
with smooth edges along the walls and no evidence of
neovascularization in the capillary bed (deeper, smaller
vessels). In contrast, at 24 weeks, Cbsþ/ mice had large
vessels that manifested numerous small constrictions along
their length, giving them a saccular, beaded appearance
(Figure 1E). Within the capillary bed, there was clearThe American Journal of Pathology - ajp.amjpathol.orgevidence of vascular leakage (Figure 1E). By 1 year, there
were many microaneurysms in the capillary bed and evi-
dence of new blood vessels (Figure 1F). Fluorescein leakage
was evaluated by comparing the color measurement for
ﬂuorescein from images collected after 1, 2, and 3 minutes
of ﬂuorescein injection in both Cbsþ/þ and Cbsþ/ mice
using the ImageJ software program. Data were subjected to
statistical analysis (Figure 1G). FA of Cbsþ/ mice retinas
revealed signiﬁcant leakage of ﬂuorescein at 24 weeks, and
the leakage was progressive as mice aged (52 weeks).
In humans, HHcy has been implicated in occlusion of the
central retinal vein, branch retinal veins, and the central
retinal artery.14e16 We noticed, from our FA studies, evi-
dence of vascular occlusion in some Cbsþ/ mouse retinas.
A darkened area that is ischemic, adjacent to a dilated retinal
vein, was observed (Figure 1H). Also evident were ischemic
nodules (small pale green circular structures), ﬂuorescein
leakage (diffuse pale green areas), and hemorrhagic spots
(dark area). Thus, in addition to the vascular leakiness we
observed in the mutant mice, there also were incidences of
occlusion that are reminiscent of the vascular phenotype of
some humans with HHcy.
To obtain information about retinal structure in live ani-
mals of advanced age, OCT was performed. Mice were used
at 52 weeks (Cbsþ/þ and Cbsþ/). In the volume image
projections of retinas of Cbsþ/þ and Cbsþ/ mice, the
B-scans revealed normal retinal architecture in Cbsþ/þ mice
(Figure 1J), but disrupted areas in Cbsþ/ mouse retina
(Figure 1M). There is evidence of unusual structures within
the vitreous (Figure 1M), which were pulsating during im-
aging, suggesting that they may be aberrant vessels in the
vitreous. From the B-scans, the software allows three-
dimensional renderings. The renderings of the Cbsþ/þ
mouse retina showed no surface disruption (Figure 1K),
whereas the Cbsþ/ inner retina had an uneven appearance
(Figure 1N). There is evidence also of debris in the vitreous
cavity (Figure 1N), which was not observed in the Cbsþ/þ
retina. These structures correspond to the presumptive
vitreal blood vessels observed in the B-scans (Figure 1M).
Quantitative Assessment of Retinal Vasculature
We examined retinal vasculature in older Cbsþ/þ and Cbsþ/
mice (52 weeks) using isolectin-B4 in retinal ﬂat mounts
(Figure 2, AeE and HeL). In retinas of Cbsþ/þ mice,
multiple arteries branched from the central retinal artery
(Figure 2A). An extensive capillary network was visible
between branches. The well-deﬁned branching pattern
characteristic of Cbsþ/þ mice was not observed in the retinas
of Cbsþ/ mice (Figure 2H). A large capillary-free zone was
observed in the central part of the retina (Figure 2, I and K)
in the Cbsþ/ mice compared with the wild-type Cbsþ/þ
mice, which had an intact capillary network (Figure 2, B and
D). Capillary tufts and dilations were observed in the pe-
ripheral areas of Cbsþ/ mice (Figure 2, J and L) compared
with normal vasculature in retinas of Cbsþ/þ mice (Figure 2,2577
Figure 1 Retinal ﬂuorescein angiographic and
OCT assessment of Cbsþ/þ and Cbsþ/ mice. FA was
performed in 16- to 52-week-old Cbsþ/þ and Cbsþ/
mice. Representative angiograms for Cbsþ/þ and
Cbsþ/ at ages 16 (A), 24 (B), and 52 (C) weeks. Top
panels: Bright ﬂuorescence reﬂects vessel ﬁlling, and
diffuse pale green areas typically signify vascular
leakage.Bottompanels: Imageswere processed using
the Adobe Photoshop threshold feature to permit
visualization of vessels. Higher-magniﬁcation images
of the FAdata showwell-formed vessels in Cbsþ/þmice
(D) and new vessels with beading along vessel length
in the Cbsþ/ mouse retinas (yellow arrows, E).
Higher-magniﬁcation image from 52-week-old mice
(F) shows perivascular ﬂuorescein leakage (white ar-
rows). The yellow line (C and F) outlines a central
area with decreased ﬂuorescein ﬁlling (nZ 6 mice
per group per age). G: Quantiﬁcation of the FA data
(ﬂuorescent intensity) used the ImageJ software
program. H: High-magniﬁcation FA image (Cbsþ/
mouse, 16 weeks) shows central ischemic area (pink
encircled area). Small arrows indicate ischemic
nodule; medium arrows, leakage; and large ar-
rows, hemorrhage. OCT was performed in Cbsþ/þ
and Cbsþ/ mice (52 weeks). Representative vol-
ume intensity projection (VIP) for Cbsþ/þ (I) and
Cbsþ/ (L) mice. B-scans of Cbsþ/þ (J) and Cbsþ/
(M) mice. White arrows in M and N indicate aber-
rant structures in vitreous. Yellow arrows in M
indicate intraretinal blood vessels. Three-
dimensional renderings of the en face images of
retinas of Cbsþ/þ (K) and Cbsþ/ (N) mice.
*P< 0.05, **P< 0.01 (nZ 29) (G). Scale bars: 800
mm (AeC); 400 mm (DeF and H). RV, retinal vein.
Tawﬁk et alC and E). Collectively, these data suggested ischemia in the
central retina of the HHcy mice and new blood vessel for-
mation in the periphery.
Retinal ﬂat mount preparations were subjected to quan-
titative analysis to compare the retinal blood vessel param-
eters of the Cbsþ/þ versus Cbsþ/ mice (Figure 2, OeQ and
ReT). To quantify the extent of ischemia, we measured the
capillary-free zones (Figure 2O), which were statistically2578different between Cbsþ/þ and Cbsþ/. We also measured
the area covered by vasculature (Figure 2P) in the two
groups of mice, which did not differ signiﬁcantly, and the
numbers of branch points of the retinal peripheral capillary
network (Cbsþ/þ versus Cbsþ/, 32.6  9.9 versus
36.3  15.3), which were not statistically signiﬁcant. There
was a signiﬁcant difference in the measurements of the
capillary-free zones. These data suggest that there may beajp.amjpathol.org - The American Journal of Pathology
Figure 2 Quantitation of altered retinal
vasculature in Cbsþ/ mice. Retinal ﬂat-mount
preparations were stained with isolectin-B4
(endothelial cell marker) to label retinal vascula-
ture. Representative ﬂat-mount preparations from
52-week-old Cbsþ/þ (A) and Cbsþ/ (H) mice.
Central retina: low (B and I) and higher (D and K)
magniﬁcation of the central retina for Cbsþ/þ and
Cbsþ/mice, respectively. Peripheral retina: low (C
and J) and (E and L) higher magniﬁcation of pe-
ripheral retina for Cbsþ/þ and Cbsþ/ mice,
respectively. Arrows (J and L) point to neovascular
tufts in peripheral retina of Cbsþ/mouse. Analysis
of the area of capillary dropout (O), the area
covered by vasculature (P), and the vessel tortu-
osity (Q) was performed in Cbsþ/þ and Cbsþ/
mouse retinas (nZ 5 mice per group). Analysis of
arterioles and venules is shown for Cbsþ/þ (F and G)
and Cbsþ/ (M and N) mice. Analysis of the width of
the arterioles (R) and the venules (S) was calcu-
lated for the mice in each group (n Z 6). T:
Quantiﬁcation of the ratio of the width of the
arteriole and venule (n Z 6 mice per group).
*P < 0.05, ***P < 0.001. Scale bar Z 100 mm
(A, D, E, and H).
Mild HHcy and Retinal Vasculopathycompensation for ischemia detected in Cbsþ/ retinas
through the formation of new blood vessels. We evaluated
the vessel tortuosity by dividing the vessel branch length by
the euclidean distance. There was a signiﬁcant increase in this
value, suggesting an increase in blood vessel tortuosity in theThe American Journal of Pathology - ajp.amjpathol.orgCbsþ/ mice compared with the Cbsþ/þ mice (Figure 2Q).
The widths of retinal arterioles and venules were analyzed in
Cbsþ/þ mice (Figure 2, F and M) versus Cbsþ/ mice
(Figure 2, G and N). There was no statistical difference in the
arteriole width (Figure 2R); however, there was a signiﬁcant2579
Figure 3 Detection of hypoxia and angiogenesis. A: Immunostaining of retinal ﬂat-mount preparations from Cbsþ/þand Cbsþ/ mice for isolectin-B4 (red)
visualizes vasculature, and hypoxyprobe-1 (green) detects ischemic areas. B: Quantiﬁcation of the data obtained from analysis of color intensity of HP-1
(n Z 6). C: Immunoﬂuorescent detection of VEGF (green) and isolectin-B4 (red) in retinal cryosections from 36-week-old Cbsþ/þand Cbsþ/ mice.
D: qPCR analysis of VEGF gene expression in 12- and 52-week-old Cbsþ/þand Cbsþ/ mice. E: Western blot analysis of VEGF levels in retinas of Cbsþ/þ and
Cbsþ/ mice. F: Quantitative analysis of VEGF protein levels in Cbsþ/þ versus Cbsþ/ mice (n Z 3 per group). G: Immunoﬂuorescent staining of retinal
cryosections from 52-week-old Cbsþ/þand Cbsþ/ mice detects endoglin (CD105, red); DAPI (blue) detects nuclei. Red ﬂuorescence labels endoglin
(top panels), and merged images with DAPI (blue) allow localization within the retinal nuclear layers (bottom panels). Experiments were performed in
sections from six mice per group. H: Quantiﬁcation of the data (endoglin color intensity) obtained using MetaMorph imaging software version 6.3 (n Z 6).
*P < 0.05, **P < 0.01, and ***P < 0.001. Scale bar Z 50 mm (A and G). GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.
Tawﬁk et alincrease in the venule width (Figure 2S) and a decrease in the
ratio of arteriole/venule width (Figure 2T). Taken together,
the analysis of the vasculature provides evidence of ischemia
in the Cbsþ/ mice retina.
Assessment of Retinal Ischemia and Angiogenesis
HP-1 is widely used as a marker of hypoxia. The Cbsþ/þ
and Cbsþ/ mice were injected with HP-1 and were sub-
sequently euthanized for preparation of retinal ﬂat mounts
that were incubated with antibody against HP-1 and
isolectin-B4 to detect blood vessels. Mice were evaluated at
16, 24, and 36 weeks. Data from 24 weeks (Figure 3A)
showed the retinal ﬂat mounts from Cbsþ/þ and Cbsþ/
mice. The Cbsþ/þ mice had well-deﬁned vascular beds; the
HP-1 staining was minimal and limited to venules, which
reﬂects their decreased oxygen levels. The merged image
shows no hypoxia within the retinal tissue. Retinas of the
Cbsþ/ mice showed hypoxic areas (green-stained retinal
tissue), particularly in the regions where there was abnormal
vasculature (Figure 3A). These data were conﬁrmed by2580measuring ﬂuorescent intensity levels in Cbsþ/ and Cbsþ/þ
mice retinas, which revealed a signiﬁcant increase in retinal
ischemia in the mild HHcy mice compared with age-
matched wild-type mice (Figure 3B).
VEGF is a 40-kDa dimeric glycoprotein that is a potent
endothelial cell mitogen. It stimulates proliferation, migra-
tion, and tube formation, leading to growth of new blood
vessels.28 Figure 3C shows immunoﬂuorescent detection of
VEGF in retinal cryosections from Cbsþ/þ mice and Cbsþ/
mice. In studies in which the primary antibody was omitted
(negative control) or when IgM was used in place of the
primary antibody (isotype control), there was no signal
detected (data not shown). To evaluate whether there were
differences in levels of VEGF at the gene and protein levels,
RT-qPCR and Western blot analysis were performed. RT-
qPCR showed an early trend of increased VEGF mRNA
(12 weeks), although this trend did not persist by age 52
weeks (Figure 3D). Immunoblotting studies to detect the
level of VEGF protein demonstrated an increase in VEGF
levels in theCbsþ/mice retinas at age 36 weeks (Figure 3E).
The membranes were subjected to densitometric scanning ofajp.amjpathol.org - The American Journal of Pathology
Figure 4 Analysis of gliosis and perivascular cells in Cbsþ/ mouse retina. GFAP levels were detected in Cbsþ/þ and Cbsþ/ mice (shown here at 36 weeks)
by immunoﬂuorescence in retinal ﬂat mounts (arrow, A) and retinal cryosections (B). C: GFAP levels in cryosections were quantiﬁed using the MetaMorph
analysis system to measure color intensity (nZ 6). D: Retinal ﬂat-mount preparations from Cbsþ/þ and Cbsþ/ mice (at age 52 weeks) stained for pericyte-
speciﬁc marker NG2 and endothelial cell marker isolectin-B4. E: High-resolution (ultrastructural) images of retinal blood vessels from Cbsþ/þ and Cbsþ/ mice.
*P < 0.05. Scale bar Z 50 mm (A, B, and D). e, endothelial cells; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; P, pericyte.
Mild HHcy and Retinal Vasculopathythe bands normalized to b-actin (loading control) and showed
approximately twofold increase of VEGF in theCbsþ/mice,
compared with Cbsþ/þ retinas (Figure 3F).
Endoglin (CD105) is a proliferation-associated, hypoxia-
inducible protein abundantly expressed in angiogenic
endothelial cells29; it is used as a marker for new blood
vessels. To conﬁrm neovascularization in retinas of Cbsþ/
mice, endoglin levels were analyzed by immunoﬂuores-
cence in retinal cryosections (Figure 3G). Endoglin was
detected minimally in the neural retinas of Cbsþ/þ mice,
whereas in retinas of Cbsþ/ mice, endoglin was detected
in multiple retinal layers, including the ganglion cell and
inner nuclear layers. Quantiﬁcation of the color intensity
for the endoglin ﬂuorescence showed signiﬁcantly more
intensity in the mutant retinas than age-matched wild-
type mice (Figure 3H). These data provide evidence of
angiogenic activity in retinas of the Cbsþ/ mice. Taken
collectively, the data from studies of VEGF and endoglinThe American Journal of Pathology - ajp.amjpathol.orgsupport new blood vessel formation in the retinas of HHcy
mice.
Evaluation of Glia and Perivascular Cells
GFAP is a 54-kDa intermediate ﬁlament protein that is a
major constituent of retinal astrocytes. Retinal ﬂat mount
preparations from Cbsþ/þ and Cbsþ/ mice were subjected to
immunoﬂuorescence detection of GFAP and isolectin-B4 to
examine GFAP labeling of astrocytes in conjunction with
blood vessels. In the Cbsþ/þ retinas, GFAP-positive astro-
cytes are evident; they have a star-shaped appearance, with
processes emanating from the center. A few astrocytes are
labeled that are ensheathing well-organized blood vessels
(Figure 4A). In contrast, in the Cbsþ/ retinas, there are more
GFAP-labeled astrocytes, which have diffuse branching pat-
terns and a ragged appearance. In addition, more GFAP is
notable at the areas of contact of astrocytes with the isolectin-2581
Figure 5 Occludin and ZO-1 expression in Cbs mouse retina. Retinal ﬂat
mounts from Cbsþ/þ and Cbsþ/micewere incubatedwith an antibody against
occludin (arrows, A) and ZO-1 (arrows, B), markers of tight junctions. C:
Retinal protein was extracted, subjected to SDS-PAGE, and immunoblotted to
detect ZO-1 (MrZ 198 kDa) and occludin (MrZ 59 kDa); b-actin was used as
the loading control. D: Quantiﬁcation of densitometric scans of protein bands
shows a signiﬁcant decrease in occludin and ZO-1 expression in the 52-week-
old Cbsþ/ mice. *P < 0.05 (nZ 6). Scale barZ 50 mm (A and B).
Tawﬁk et alB4elabeled vessels, and the blood vessels also appeared
disrupted (Figure 4A). Up-regulation of GFAP levels in
retinal Müller cells is a sensitive indicator of retinal stress.30
Retinal cryosections from 36-week-old Cbsþ/þ and Cbsþ/
mice were subjected to immunoﬂuorescence detection of
GFAP (Figure 4B). In the Cbsþ/þ retinas, GFAP labeling was
detected in the nerve ﬁber layer and the outer plexiform layer,
which is a normal distribution pattern. In the Cbsþ/ mouse
retina, there was a marked increase in the intensity of GFAP
labeling, consistent with activation of Müller glial cells. The
MetaMorph analysis of the color intensity in the GFAP-
labeled cryosections revealed a marked increase in GFAP
levels (Figure 4C). The data suggest that a reactive gliosis
may accompany HHcy in mild HHcy in Cbsþ/ retinas.
Blood vessels are composed of two interacting cell types:
endothelial cells, which form the inner lining of the vessel wall;
and pericytes, which envelop the surface of the vascular tube.
Pericytes possess a cell body with a prominent nucleus and
small content of cytoplasm with several processes embracing
the endothelial cells.31 Pericytes communicate with endothelial
cells by direct physical contact and paracrine signaling path-
ways. Gap junctions provide direct connections between the
cytoplasm of pericytes and endothelial cells.32 Pericytes are
functionally signiﬁcant during vessel growth, vessel mainte-
nance, and pathological angiogenesis; when vessels lose peri-
cytes, they become hyperdilated and hemorrhagic.32 Retinal
ﬂat mount preparations from Cbsþ/þ and Cbsþ/ mice were
subjected to immunoﬂuorescence to detect pericytes using the
marker NG2 and isolectin-B4. In the Cbsþ/þ retinas, NG2-
positive pericytes are prominent and extend well-deﬁned
endothelium-associated processes (Figure 4D). In contrast, in
the Cbsþ/ retinas, pericytes are partially detached and extend
processes away from the endothelial cells (Figure 4D). The
observations of changes in perivascular cells shown in immu-
nohistochemistry using the anti-NG2 antibody are intriguing in
light of reports of perivascular disruption observed in Pdgfb
mutant mice.We investigated the ultrastructural morphological
characteristics of the pericytes in theCbsþ/þ andCbsþ/mouse
retinas by electron microscopy (Figure 4E). High-resolution
images of Cbsþ/þ blood vessels revealed normal-appearing
pericytes (prominent nucleus/thin rim of cytoplasm), whereas
the images of Cbsþ/ blood vessels showed pericytes with
degenerated cytoplasmic remnants and occasional ghosts of
former pericytes. Examination of Cbsþ/ mouse retinas
showed pericyte disruption in nearly all blood vessels (>90%)
examined, whereas disrupted pericytes were rarely observed in
the wild-type mice (<5%).
Examination of Inner Blood-Retinal Barrier Proteins
Newly formed blood vessels are often immature and leaky.33
The data showing new blood vessel formation in retinas
of Cbsþ/ mice (Figures 1 and 2), coupled with increased
expression of VEGF (Figure 3), prompted investigation of
markers for an intact blood-retinal barrier. Maintenance of the
blood-retinal barrier is essential for retinal homeostasis. The2582tight junction proteins occludin and ZO-1 contribute to the
retinal permeability barrier and are present in endothelial and
epithelial cells.34,35 Occludin and ZO-1 levels were investi-
gated by immunoﬂuorescence in retinal ﬂat mounts (Figure 5).
A uniform pattern of occludin labeling was detected in retinal
vessels of Cbsþ/þ mice, whereas multiple gaps in occludin
expressionwere observed in the retinal blood vessels ofCbsþ/
mice by the age of 52 weeks (Figure 5A). Similarly, for ZO-1,
the labeling pattern was uniform in Cbsþ/þ mice but appeared
disrupted in theCbsþ/ retinal vasculature (Figure 5B). Retinal
protein was isolated from Cbsþ/þ and Cbsþ/ mice and sub-
jected to immunoblotting to detect levels of occludin and ZO-1
(Figure 5C). Examination of these proteins in mice (aged 36ajp.amjpathol.org - The American Journal of Pathology
Mild HHcy and Retinal Vasculopathyweeks) showed a decrease in occludin and ZO-1, but the data
did not reach statistical signiﬁcance (data not shown). How-
ever, when proteins harvested from 52 weeks were examined,
densitometric quantiﬁcation revealed a signiﬁcant decrease in
occludin and ZO-1 in Cbsþ/ retinas compared with Cbsþ/þ
retinas (Figure 5D). The decreased levels of the two tight
junction proteins suggest compromised integrity of the blood-
retinal barrier.Discussion
The current study examined retinal vasculature under condi-
tions of mild to moderate HHcy using the Cbs mutant mouse
as a model system. The work was prompted by our earlier
studies that provided compelling evidence that severe HHcy
was associated with alteration of retinal vasculature, including
ischemia concomitant with neovascularization.26 By using
young Cbs/ mice, which lack a key enzyme in the trans-
sulfuration pathway, CBS, we observed retinal hemorrhage,
central capillary dropout, and midperipheral new blood vessel
formation, increased retinal levels of biological markers of
angiogenesis (CD105 and VEGF), increased expression of
GFAP in astrocytes and Müller cells, consistent with reactive
gliosis, and decreased levels of the tight junction proteins
ZO-1 and occludin. In vivo studies using ﬂuorescein angiog-
raphy reﬂected retinal vascular leakage. The study was limited
to examination only at 3 weeks of age owing to the shortened
lifespan of the Cbs/ mouse. In that same study, we exam-
ined the vasculature of age-matched heterozygous (Cbsþ/)
mice, which showed minimal vascular alterations. Neverthe-
less, the question of whether mild to moderate Hcy elevation,
which is much more common in the human population than
severe elevation (eg, homocystinuria), results in a retinal
vasculopathy remained. Furthermore, it remained unknown
how vasculopathy progressed. Earlier morphological and
functional studies using Cbsþ/ mice showed a progressive
loss of neurons in the inner retina, particularly retinal ganglion
cells,22 and a progressive decrease of the dark-adapted ERG
A- and B-wave amplitudes and luminance-response functions,
especially with advancing age (15 and 30 weeks).25 There has
been no analysis of the retinal vasculature in these mice; the
present study ﬁlls that void.
The comprehensive analysis of retinal vasculature inCbsþ/
mice spanned many weeks (16 to 52) beginning with in vivo
assessments in anesthetized mice using FA and OCT. Angio-
grams for Cbsþ/ at early ages (16 weeks) showed only mild
alterations, but with advancing age, evidence of tortuous ves-
sels and ﬂuorescein leakage increased. By 1 year, capillary tufts
and dilations were observed frequently. The OCT scans
conﬁrmed this progression, and by 1 year, there was evidence
of altered vessels, including, occasionally, vessels in the vit-
reous of some mice.
These in vivo studies were complemented by a compre-
hensive analysis of retinal vessels in ﬂat-mounted retinal
preparations, including quantitative determination of vesselThe American Journal of Pathology - ajp.amjpathol.orgparameters. These studies, performed in mice at 21 to 52
weeks, showed a decreased arteriole/venule ratio (AVR) and
increased area of capillary dropout, increased vessel density,
increased vessel branch points, increased vessel tortuosity,
and increased venule width in Cbsþ/ retinas compared with
wild type. The increased area of capillary dropout, concom-
itant with altered vessel density and branch points, suggests
ischemia compensated by neovascularization. The prevailing
opinion had long been that decreased AVR reﬂected a
generalized arteriolar narrowing; however, it is now clear that
increased venule diameter can also cause decreased AVR.36
This was the case with the Cbsþ/ retinas. The venules in
Cbsþ/ mice were approximately 20% wider than in Cbsþ/þ
mice, leading to an approximately 25% decrease in AVR in
the mutant mouse compared with wild type. These data are
consistent with the notion that venular diameters do not
necessarily remain constant in different pathological states
and may be predictive for vascular disease. Data analyzed as
part of the Rotterdam study have demonstrated that larger
retinal venular diameters are associated with an increased risk
of stroke and cerebral infarction.37
As the Cbsþ/ mice aged, evidence of vasculopathy
increased, such that by 36 weeks, there were more capillary
tufts and dilations observed in retinal ﬂat-mounted prepara-
tions. Careful scanning of ﬂat mounts revealed that the central
retina tended to be ischemic, whereas the peripheral retina had
more new blood vessels. To detect ischemia, the ﬂat-mounted
retinas were subjected to detection of hypoxia using a pimo-
nidazole hydrochloride probe, which showed considerably
more hypoxic areas in Cbsþ/ mutant mice compared with
age-matched Cbsþ/þ mice. To investigate new vessels, two
markers, VEGF and CD105, were used in retinal cryosections
that allow investigation of the primary vascular plexus and the
inner-deeper vascular plexus. Our data show that levels of both
of these markers increased in retinas of the Cbsþ/ mice,
providing important evidence that with advancing age new
blood vessels are emerging in retinas of the mildly HHcy an-
imals. Increased VEGF levels are implicated in several retinal
diseases, including diabetic retinopathy and age-related mac-
ular degeneration.28,38 More important, there are reports of a
correlation between Hcy and these diseases as well.39e44 In
addition to our ﬁndings of increased markers for new retinal
vessels in the Cbsþ/ mice, we also assessed the involvement
of retinal glial cells that ensheath blood vessels, particularly
astrocytes, and found that there is an increase in GFAP, a glial
cell marker in the ﬂat-mounted preparations. There was
increased expression of GFAP detected in the cryosections,
reﬂecting Müller cell activation. Our data suggest ischemia,
characterized by neovascularization and pericyte loss. Peri-
cytes provide stability for blood vessels and control endothe-
lial cell proliferation. Assessment of the pericytes in retinas of
the Cbsþ/ mice revealed abnormal pericytes and pericyte
loss. These characteristics have been described in other mouse
models with microvascular abnormalities, such as the Pedfb
mutant mouse, which manifests altered pericytes in retina45
and brain.462583
Tawﬁk et alOne of the most interesting aspects of the effects of HHcy
on vasculature is increased permeability of the blood-brain
barrier.47 An evaluation of microvasculature in brains of
Cbsþ/mice at 2 and 9 months found increased permeability
at both ages compared with wild-type mice. The older mice
also demonstrated leukoaraiosis, inﬂammation in the fornix,
and cognitive impairment.48 In our studies, we too observed
evidence of compromised blood-retinal barrier in the Cbsþ/
mouse. Notably, there was a decrease in the expression of
two key tight junctional proteins within the vasculature
(namely, occludin and ZO-1). The leakiness that we observed
in the in vivo FA studies likely reﬂects blood-retinal barrier
compromise, and our ﬁndings of decreased junctional pro-
teins may contribute to this phenomenon. Marked vascul-
opathy in other tissues has been reported in this mousemodel.
For example, morphological changes have been observed in
the large vessel walls, including increased thickness and
hypertrophy.48 Decreased dilatory response of large arteries,
such as aorta and the carotid artery, was observed compared
with vessels isolated from control animals, after experimental
application of endothelium-dependent vasodilators.49 Our
studies of retinal vasculature in the Cbsþ/ mice revealed
increased expression of markers of angiogenesis, whereas in
studies of hind limb vessels in the Cbsþ/ mice, there was
impaired angiogenesis.50
Taken collectively, the data obtained in this study provide
compelling evidence that a broad spectrum of vascular
sequelae accompany mild HHcy in this model and that vas-
culopathy progresses with age. The ﬁndings of the current
study and the earlier work showing retinal neuron loss22e24
raise important questions about retinal neurovascular
degeneration and HHcy. There are several retinal diseases
that have implicated HHcy in their pathogenesis, including
several types of glaucoma,5e7 various retinal occlusive
conditions,13e16 maculopathies,8e10 and diabetic retinop-
athy.11,12 However, the link between elevated Hcy and any of
these conditions varies considerably, probably because of the
myriad causes for HHcy. HHcy can be caused by nutritional
deﬁciencies and genetic mutations of enzymes involved in
remethylation or trans-sulfuration pathways. In the reme-
thylation pathway, there can be mutations of two enzymes
(methylene tetrahydrofolate and methionine synthase), and in
the trans-sulfuration pathway, there can be defects in CBS or
cystathionine g lyase. For each of these enzymes, there have
been numerous genetic mutations reported (>150 associated
with the CBS alone), making it challenging to predict that an
individual will develop HHcy-induced retinopathy. It is
important to recognize that the data presented herein reﬂect
comprehensive assessment of retinal phenotype associated
with HHcy because of the approximately 50% decrease in the
enzyme. The vasculopathy we observed may be attributed to
the excess levels of Hcy, but there is an alternative expla-
nation: a decrease in the downstream beneﬁcial products
produced when levels of CBS are normal [namely, gluta-
thione (GSH), taurine, and hydrogen sulﬁde (H2S)].
21 GSH is
a key antioxidant in the retina, taurine is the most abundant2584amino acid in the retina, and H2S is a gasotransmitter with
neuroprotective properties. Previous studies showed that
retinal GSH levels are similar between Cbsþ/ and wild-type
mice, but levels of taurine and H2S remain to be investigated.
One approach to determine whether the ﬁndings of this study
reﬂect direct effects of HHcy on retinal vasculature or the
consequence of the loss of these downstream products could
assess effects on retina when HHcy is due to a defect in the
remethylation pathway. Studies are now under way to
determine whether mice with HHcy due to a deﬁciency of
methylene tetrahydrofolate reductase (but an intact tran-
sulfuration pathway) present a similar retinal vascular
phenotype as reported herein for the CBS-deﬁcient mice.Acknowledgments
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